Bioactivity | Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity[1]. |
Name | Lipustobart |
CAS | 2639481-06-2 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022. |